PTC Therapeutics | PTCT - Mitarbeiter Gesamtzahl

Aktienkurs
65.30
Täglich Wechseln
-1.78 -2.65%
Monatlich
-7.38%
Jährlich
14.28%
Q1 Prognose
63.34




Mitarbeiter Veränderung Datum
Acadia Pharmaceuticals 653 56 2024-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amgen 28K 1.3K 2024-12
BioCryst Pharmaceuticals 536 5 2023-12
Biogen 7.6K 35 2024-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Cytokinetics 498 75 2024-12
Daiichi Sankyo 19.76K 1.04K 2025-12
Enanta Pharmaceuticals 145 15 2023-09
Esperion Therapeutics 240 41 2023-12
Gilead Sciences 17.6K 400 2024-12
Incyte 2.62K 93 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Ironwood Pharmaceuticals 267 48 2023-12
Karyopharm Therapeutics 325 60 2023-12
Novartis USD 101.7K 2.62K 2022-12
Pfizer 81K 7K 2024-12
PTC Therapeutics 939 49 2024-12
Puma Biotechnology 185 7 2023-12
Roche Holding 103.61K 2.69K 2022-12
Sangamo BioSciences 405 73 2023-12
Sarepta Therapeutics 1.37K 58 2024-12
TG Therapeutics 338 74 2024-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Vertex Pharmaceuticals 6.1K 700 2024-12
Xencor 250 30 2024-12